Anne Wojcicki accused of running "biological Ponzi scheme" with 23andMe
By ethanh // 2024-11-26
Copy
 
The 23andMe scandal is blowing open in a major way after a thread dropped on X / Twitter that tells the criminal history of the company and how its leadership was practicing medicine without a license. Dr. Jack Cruse (@DrJackKruse) tells the story of how Anne Wojcicki, the sister of deceased former YouTube CEO Susan Wojcicki, was running a "biological Ponzi scheme" that bilked people out of billions. The scheme started in 2007, only to be found out and addressed in 2013 when a letter was sent to 23andMe warning that what it was doing was illegal. Even so, the business continued. By 2014, more than half a million Americans had sent away their saliva samples to learn about their alleged risk of genetic illness. "Sergey money paid for propaganda ads in print, social media and on TV by splashing ads across media nationwide in 2012-2013," Dr. Kruse explains. "It was 23andMe's invitation to give you the ability to share your data with Anne and Sergery so they could discover 'hundreds of things about your health,' and sell it to whoever would pay for it. It was Big Tech creating the HARPA. This is where DARPA became HARPA." "This was the time that Paula Casey Means was learning this business model. She worked at 23andMe back in those formative years. When the FDA blocked Anne's plan, Paula realized maybe I need an MD after all to play in the HARPA sandbox?" (Related: In case you missed it, be sure to check out our earlier report about how every board member at 23andMe except for Wojcicki resigned back in September under suspicious circumstances.)

FDA goes after 23andMe

From the very beginning, 23andMe was operating outside the bounds of the law but with the government's blessing. There were no regulations imposed upon the company's infamous at-home testing kits; all a person has to do is fork over the cash, click a button, and voila: the "first step in prevention" to "mitigate serious diseases" is achieved, or so the company claims. It turns out that the author of the 2013 warning letter was none other than the U.S. Food and Drug Administration (FDA), which finally stepped in to prohibit 23andMe from continuing to sell products to diagnose health conditions unless the company could prove with evidence that the science backs it. 23andMe responded to the FDA's warning letter by "suspending" all sales of its "health-related genetic tests to comply." Consumers then brought a class-action suit against the company, accusing it of "falsely and misleadingly advertis[ing]" its genetic testing kit "as providing 'health reports on 240+ conditions'" in the absence of "analytical or clinical validation."

The Paula Casey Means connection

More recently, Wojcicki, as previously mentioned, tried to take 23andMe public, only to have the entire board except for herself resign. Apparently, nobody on the board sees her vision for the company as viable or even valid. After expressing interest in acquiring the company back in April, Wojcicki a few months later in July would suddenly submit a proposal to take the company private. The board's Special Committee rejected Wojcicki's proposal, explaining that she failed to provide a premium to the closing price at the time when the stock price was 40 cents per share. Not only that, but Wojcicki's proposal lacked committed financing. Wojcicki was afforded a "limited amount of additional time" by the Special Committee to address these changes in her proposal, but she apparently never responded because here is what the board members wrote to her just two months ago: "After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders." Dr. Kruse warns that Paula Casey Means and her family are possible investors in Wojcicki's idea, which Dr. Kruse refers to as "Big HARPA." Describing Wojcicki as a "data thief," Dr. Kruse says that nobody wants to support except for Means and her family. All that DNA data, by the way, is worthless because mtDNA controls the epigenetic expression of nuclear DNA. The only thing DNA collection schemes like this accomplish is to funnel large amounts of people's cash into the hands of a few, in this case Wojcicki and her friends. "This idea is buried at the base of decentralized science which is 180 degrees opposite centralized medicine ideas of 23andMe, Levels, and TrueMed," Dr. Kruse explains about the mtDNA concept. "Investors have spoken loudly. So now the tables have turned into getting into seats in government where policy can change these market forces? We'll see soon." Like many other such Ponzi schemes, 23andMe appears to be little more than a Wall Street pump-and-dump scheme. It is profitable for some, mainly those who dump the stock early, leaving everyone behind them to hold the bag. "Even centralized medical scammer Scott Gottlieb's Illumina, the flagship DNA sequencing company, is struggling!" Dr. Kruse notes. "Remember he is the regulator of the FDA who left government to work for Pfizer and then became a talking head on CNBC to shill his BigHarma bags." "After the entire human genome can be sequenced for $100 – no growth. What, nobody needs their computer-generated garbage for anything, even when it only costs one Benjamin?" Dr. Kruse recommends using Yandex to search for more information about all this as opposed to Google since Google's SEO "is being used to help Anne." More related news about all this and more can be found at Corruption.news. Sources for this article include: X.com NaturalNews.com
Copy